BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Clinical Innovation Platform - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://clinicalinnovation.ca
X-WR-CALDESC:Events for Clinical Innovation Platform
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240517T120000
DTEND;TZID=UTC:20240517T130000
DTSTAMP:20260424T100843
CREATED:20240717T152245Z
LAST-MODIFIED:20240717T152419Z
UID:1657-1715947200-1715950800@clinicalinnovation.ca
SUMMARY:Making Hospital-Based Innovation Stick
DESCRIPTION:Dr. George Tolomiczenko is the founding Executive Director of the Merkin Institute for Translational Research at Caltech. George is a Canadian who returned to Caltech after graduating forty years earlier with a self-designed degree in bioengineering. His innovations in program development and evaluation began following his doctoral training as a research-oriented clinical psychologist in Boston. They have included designing large projects on housing approaches for homelessness persons with mental illness\, strategies for technology-based regional economic development\, philanthropic funding of research\, partnerships for research talent development and programs linking engineering and medicine.\n\nFor this talk\, he will draw from his portfolio-career in both the US and Canada to offer real-life Aesopian tales rich in lessons on fostering innovation designed to survive the journey from identifying and choosing a need to establishing a sustainable solution.
URL:https://clinicalinnovation.ca/event/making-hospital-based-innovation-stick/
LOCATION:Clinical Innovation Platform\, 1650 Avenue Cedar\, Floor C9 ( Across from the ICU)\, Montréal\,\, QC\, H3G 1A4\, Canada
ATTACH;FMTTYPE=image/jpeg:https://clinicalinnovation.ca/wp-content/uploads/2024/07/GT.jpg
ORGANIZER;CN="Clinical Innovation Platform":MAILTO:clip.ri@muhc.mcgill.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231130T120000
DTEND;TZID=UTC:20231130T130000
DTSTAMP:20260424T100843
CREATED:20231120T201102Z
LAST-MODIFIED:20231122T192617Z
UID:1379-1701345600-1701349200@clinicalinnovation.ca
SUMMARY:Maximizing your startup potential with experts who've seen it all: The good\, the bad\, and the avoidable mistakes
DESCRIPTION:Dive into the world of product development as the CEO of CLEIO\, Alexis Bilodeau\, will talk about the benefits of harnessing external expertise tailored specifically for startups. Discover actionable insights on effective collaboration with product design firms and gain a comprehensive overview of our specialized work. We’ll showcase how we can help startups build solid foundations by sharing real-life case studies illustrating successful collaborations and mistakes avoided. \nCLEIO: By combining strategy\, design\, and engineering talents\, we offer an integrated ISO 13485-certified approach to medical device development and high-tech product development. Since 2005\, we have worked together to develop the best solution from the earliest stages of a product definition to production. We support both high-potential start-ups that need resources to bring revolutionary new technologies to life and established organizations looking for new sources of innovation and growth. \nRegister here: https://www.eventbrite.ca/e/760794445667?aff=oddtdtcreator
URL:https://clinicalinnovation.ca/event/maximizing-your-startup-potential-with-experts-whove-seen-it-all-the-good-the-bad-and-the-avoidable-mistakes/
LOCATION:Clinical Innovation Platform\, 1650 Avenue Cedar\, Floor C9 ( Across from the ICU)\, Montréal\,\, QC\, H3G 1A4\, Canada
ATTACH;FMTTYPE=image/jpeg:https://clinicalinnovation.ca/wp-content/uploads/2023/11/Draft-McGill-Session-Visual.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231122T130000
DTEND;TZID=UTC:20231122T140000
DTSTAMP:20260424T100843
CREATED:20231024T160425Z
LAST-MODIFIED:20231121T203852Z
UID:1322-1700658000-1700661600@clinicalinnovation.ca
SUMMARY:Angel Investing\, Advising\, and Early Stage Innovation
DESCRIPTION:The healthcare industry faces numerous challenges\, and HealthTechnology startups aim to address these issues with innovative solutions. Physicians can play a vital role in solving these challenges by providing guidance\, mentorship\, and feedback to companies working on groundbreaking solutions. We will show examples of practicing physicians currently involved in startups as founders\, investors and advisors in healthcare startups.\n\nWe will demonstrate how their intimate knowledge of the healthcare landscape positions them as invaluable resources for these startups\, bridging the gap between medical expertise and entrepreneurial innovation to improve patient care and outcomes.\n\nThere will be a focus on the benefits of such endeavours including: impact to society\, professional and personal development and financial rewards.\n\nWe will also introduce the Halo Health physician angel group which has already invested in 41 startups since 2020 and removes a lot of the friction and hassle associated with getting involved in technology startups. We will discuss some of its advantages such as paid specialty-matched advisory positions\, healthcare connections and capital for early stage healthtech ventures.\nREGISTER HERE: https://www.eventbrite.ca/e/740797895447?aff=oddtdtcreator\nSpeaker:  \nDr. Thanasi Tsiodras is certified in Family and Emergency Medicine and has worked in various clinical roles since 2009. After investing in the public markets for a decade\, he got his start in the private markets with an investment in Spotify in 2014 and an IPO exit in 2017. He has been involved in startups in some capacity or another since. He was an early physician hire at Dialogue technologies (TSX:CARE and recently acquired by Sunlife).  \nHe has been an investor with Halo Health since 2020 and joined the board and investment committee in 2023. He also serves as Venture Partner for the Genesis Ventures fund based out of Athens\, Greece and as a member of Anges Quebec.
URL:https://clinicalinnovation.ca/event/angel-investing-advising-and-early-stage-innovation/
LOCATION:MUHC (GLEN site)\, 1001 boul. Decarie\, Block C - C05.1172\, Montréal\, QC\, H4A 3J1\, Canada
ATTACH;FMTTYPE=image/png:https://clinicalinnovation.ca/wp-content/uploads/2023/10/Capture-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231115T120000
DTEND;TZID=UTC:20231115T130000
DTSTAMP:20260424T100843
CREATED:20231023T182518Z
LAST-MODIFIED:20231024T152314Z
UID:1280-1700049600-1700053200@clinicalinnovation.ca
SUMMARY:Overscienced & Underfunded: How to Spin-out Your Breakthrough Ideas
DESCRIPTION:Starting any company is hard. DrMilad Alucozai will be joining us to discuss his journey from founder to venture capital investor. \nMilad’s journey began when he immigrated to the US as a child\, going on to study neuroscience\, translating research into products\, a successful entrepreneur in the biotech space\, to his current work investing in early-stage life science startups. Milad will provide insights into what he looks for in a startup\, how to spin-out of a university and turn the project into a company\, important traits of successful founders\, and how he evaluates early-stage companies as potential investments. The path to funding is rarely easy for an early-stage life science company. Implementing key practices early on can help you prepare for the future and identify issues that may create problems later. Understanding which key milestones investors seek can help you know when to engage and how to prepare in advance. Learn what sets companies apart and how to put your best foot forward. \nRegister Here/Enregistrez-vous ici: https://www.eventbrite.ca/e/738052343427?aff=oddtdtcreator \nCréer une entreprise n’est pas chose aisée. Milad Alucozai nous rejoindra pour parler de son parcours de fondateur à investisseur en capital-risque. \n\nLe parcours de Milad a commencé lorsqu’il a immigré aux États-Unis alors qu’il était enfant. Il a ensuite étudié les neurosciences\, a traduit ses recherches en produits\, a été un entrepreneur prospère dans le domaine de la biotechnologie et investit aujourd’hui dans des entreprises en phase de démarrage dans le domaine des sciences de la vie. Milad expliquera ce qu’il recherche dans une startup\, comment sortir d’une université et transformer le projet en entreprise\, les traits importants des fondateurs qui réussissent\, et comment il évalue les entreprises en phase de démarrage en tant qu’investissements potentiels. Le chemin vers le financement est rarement facile pour une entreprise de sciences de la vie en phase de démarrage. La mise en œuvre de pratiques clés dès le début peut vous aider à vous préparer pour l’avenir et à identifier les questions susceptibles de créer des problèmes plus tard. Comprendre quelles sont les étapes clés recherchées par les investisseurs peut vous aider à savoir quand vous engager et comment vous préparer à l’avance. Découvrez ce qui distingue les entreprises et comment mettre toutes les chances de votre côté.
URL:https://clinicalinnovation.ca/event/overscienced-underfunded-how-to-spin-out-your-breakthrough-ideas/
LOCATION:Clinical Innovation Platform\, 1650 Avenue Cedar\, Floor C9 ( Across from the ICU)\, Montréal\,\, QC\, H3G 1A4\, Canada
ATTACH;FMTTYPE=image/png:https://clinicalinnovation.ca/wp-content/uploads/2023/10/Capture.png
ORGANIZER;CN="Clinical Innovation Platform":MAILTO:clip.ri@muhc.mcgill.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231101T090000
DTEND;TZID=UTC:20231101T100000
DTSTAMP:20260424T100843
CREATED:20231024T155414Z
LAST-MODIFIED:20231024T155414Z
UID:1318-1698829200-1698832800@clinicalinnovation.ca
SUMMARY:Quality Health Economics in Action: Implications for Innovation
DESCRIPTION:Join us for an exciting in-person event where we will explore the fascinating world of quality health economics. At Clinical Innovation Platform\, we will be hosting MUHC CFO Mr. Nicolas Robert to discuss the latest trends and strategies in this field. \nMr. Robert will cover the current situation and plan for next few years for case costing and patient based funding limitations and opportunities. Current and future needs for innovation or reflection. \nThis is a CLIP member and affiliates exclusive event.
URL:https://clinicalinnovation.ca/event/quality-health-economics-in-action-implications-for-innovation/
LOCATION:Clinical Innovation Platform\, 1650 Avenue Cedar\, Floor C9 ( Across from the ICU)\, Montréal\,\, QC\, H3G 1A4\, Canada
ATTACH;FMTTYPE=image/png:https://clinicalinnovation.ca/wp-content/uploads/2023/10/Capture-2.png
ORGANIZER;CN="Clinical Innovation Platform":MAILTO:clip.ri@muhc.mcgill.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231025T130000
DTEND;TZID=UTC:20231025T140000
DTSTAMP:20260424T100843
CREATED:20231023T182451Z
LAST-MODIFIED:20231023T182451Z
UID:1298-1698238800-1698242400@clinicalinnovation.ca
SUMMARY:Vision for Innovation at the MUHC: Addressing the Pain Points
DESCRIPTION:Dr. Lucie Opatrny\, CEO of the MUHC\, will cover some of the “pain points” for innovation implementation and potential opportunities for solutions. This is a CLIP members exclusive event!
URL:https://clinicalinnovation.ca/event/vision-for-innovation-at-the-muhc-addressing-the-pain-points/
LOCATION:Clinical Innovation Platform\, 1650 Avenue Cedar\, Floor C9 ( Across from the ICU)\, Montréal\,\, QC\, H3G 1A4\, Canada
ATTACH;FMTTYPE=image/png:https://clinicalinnovation.ca/wp-content/uploads/2023/10/Capture-1.png
ORGANIZER;CN="Clinical Innovation Platform":MAILTO:clip.ri@muhc.mcgill.ca
END:VEVENT
END:VCALENDAR